Mohammad Hirmand
CIK 1654482 · EVP and Chief Medical Officer · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TPTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO, CA 94105
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Director | — | $3.13 | — | $0 | 2 | 2026-06-15 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | Director | — | $2.05 | — | $0 | 2 | 2024-06-14 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | EVP and Chief Medical Officer | 0 | $76.01 | $0 | -$1.26M | 5 | 2022-08-17 |
| MEDIVATION, INC. (MDVN) Delisted | Interim Chief Medical Officer | 57,523 | — | — | -$119.1K | 7 | 2016-09-19 |
Recent Filings · Page 2 of 2
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-09-19 | MEDIVATION, INC. (MDVN) Delisted | Exer (M) | +17,560 | $78.5K | EDGAR |
| 2016-04-08 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +560 | $0 | EDGAR |
| 2016-03-07 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −1,525 | -$62.7K | EDGAR |
| 2016-03-02 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +9,300 | $0 | EDGAR |
| 2015-12-04 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −1,075 | -$46.7K | EDGAR |
| 2015-11-12 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −232 | -$9.7K | EDGAR |
| 2015-10-01 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +1,190 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).